Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical pharmacology study of ranirestat (AS-3201) in subjects with renal impairment
jRCT2080222701Phase 1
- Sponsor
- Sumitomo Pharma
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ranirestat in chronic kidney disease (CKD), sponsored by Sumitomo Pharma.
02
Drugs
ranirestat
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on jRCT2080222701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222701.